Results 321 to 330 of about 2,068,221 (381)

STUDIES ON ANTIMICROBIAL SUBSTANCE B 44 P (STREPTOVARICIN) PRODUCED BY A STRAIN OF ACTINOMYCETES. I

, 1968
Hisaji Yamazaki
openalex   +2 more sources

Laser‐Induced Graphene from Wood‐Based Composites: Integrating Circuits in Bioderived Furniture

Advanced Sustainable Systems, EarlyView.
This study investigates fully bioderived wood panels made with resin from Jatropha curcas L., onto which conductive laser‐induced graphene (LIG) tracks are directly scribed. The findings obtained on functional circuits ‐ including LEDs and humidity sensors ‐ showcase the viability of combining LIG with renewable substrates for potentially sustainable ...
Anna Chiara Bressi, Lucía Pérez Amaro, Benedetto Pizzo, Attilio Marino, Gianni Ciofani, Francesco Greco   +5 more
wiley   +1 more source

Optimization of the Isolation Method for Large‐Scale Production of Synthetic Bacterial Vesicles for Cancer Immunotherapy

Advanced Therapeutics, EarlyView.
This study introduces a reliable technique for the large‐scale production of bacterial vesicles that maintain their immune‐modulating potential, enabling industrial manufacturing and clinical applications. Although other cancer immunotherapies are available, this research presents an advanced bacterial vesicle‐based therapeutic option, with scalable ...
Negar Ordouzadeh, Rossella Crescitelli, Agnes Zimmer, Petra Tjärnlund, Cecilia Lässer, Jan Lötvall, Kyong‐Su Park   +6 more
wiley   +1 more source

Boosting AMPs' Power: From Structural Engineering to Nanotechnology-Based Delivery. [PDF]

Molecules
Ajayi OE, Bellavita R, Imbò LE, Palladino S, Braccia S, Falanga A, Galdiero S.   +6 more
europepmc   +1 more source

Cytokine Engineering Approaches for Regenerative Medicine

Advanced Therapeutics, EarlyView.
Engineered cytokines represent a powerful strategy to promote tissue repair and regeneration by precisely modulating immune responses. This review highlights recent advances in cytokine engineering, including strategies to enhance half‐life, improve tissue and cell targeting, and control receptor signaling.
Shiyi Li, Wenhao You, Mikaël M. Martino
wiley   +1 more source

SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47

Advanced Science, EarlyView.
Cancer cell‐intrinsic SMYD3 orchestrates an immunosuppressive microenvironment and impairs the response to PD‐1 blockade by reprogramming immune cells landscape in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). The immunomodulatory function of SMYD3 is mediated via the SREBP1/CD47 pathway.
Zhengfang Liu, Xiumei Zhao, Maolin Zang, Huiyang Yuan, Xin Qin, Xiaofeng Li, Shuo Zhao, Ruirong Tan, Keqiang Yan, Li Liu, Yidong Fan, Ning Zhang, Benkang Shi, Bo Han, Shouzhen Chen   +14 more
wiley   +1 more source

Risk of multidrug resistance in Escherichia coli associated with routine antimicrobial prophylaxis on pig farms. [PDF]

NPJ Antimicrob Resist
Toya R, Okuno M, Sasaki Y, Yoshihara K, Deguchi Y, Nagano DS, Shimada S, Ogura Y.   +7 more
europepmc   +1 more source

Loss of NR2F6 Protects from Salmonella Typhimurium Infection

Advanced Science, EarlyView.
Loss of nuclear receptor NR2F6 reduces tissue‐resident macrophage populations. Nr2f6‐deficient mice are protected from weight loss and bacterial load during infection with Salmonella Typhimurium. Pro‐inflammatory cytokines and iron levels are altered in infected Nr2f6‐deficient mice.
Johannes Woelk, Christa Pfeifhofer‐Obermair, Julia Benz, Natascha Brigo, Milena Bamberger, Alexeja Kleiter, Martin Hermann, Guenter Weiss, Natascha Hermann‐Kleiter   +8 more
wiley   +1 more source

Correction to: GP or ChatGPT? Ability of large language models (LLMs) to support general practitioners when prescribing antibiotics. [PDF]

J Antimicrob Chemother
europepmc   +1 more source

Development and assessment of the outpatient module of the Global-PPS: a standardized approach for measuring outpatient antimicrobial prescribing. [PDF]

JAC Antimicrob Resist
Boven A, Versporten A, Pauwels I, Oshun P, Oduyebo O, Keustermans J, Brusselaers N, Vlieghe E.   +7 more
europepmc   +1 more source